C1QTNF9 and endothelial dysfunction: Specifically, extracellular vesicles (EVs) derived from ADSCs mitigate endothelial cell senescence by inhibiting miR-674-5p and upregulating the expression of C1q/TNF-related protein 9 (CTRP9), thereby improving endothelial dysfunction [46].